Oneyda Clapé-Laffita, María V. Perrand-Roberts, Milagros Domecq-Salmon, Maryenis Rodríguez-Alfaro, & Maritza Cebreco-Sardina. (2021). Safety of nimotuzumab following clinical trials in head and neck epithelial tumors. GarVal Editorial Ltda..
Chicago Style (17th ed.) CitationOneyda Clapé-Laffita, María V. Perrand-Roberts, Milagros Domecq-Salmon, Maryenis Rodríguez-Alfaro, and Maritza Cebreco-Sardina. Safety of Nimotuzumab Following Clinical Trials in Head and Neck Epithelial Tumors. GarVal Editorial Ltda., 2021.
MLA (9th ed.) CitationOneyda Clapé-Laffita, et al. Safety of Nimotuzumab Following Clinical Trials in Head and Neck Epithelial Tumors. GarVal Editorial Ltda., 2021.
Warning: These citations may not always be 100% accurate.